ClinicalTrials.gov
ClinicalTrials.gov Menu

Cognitive Training to Improve Cognitive Function Following Chemotherapy (KT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01013233
Recruitment Status : Unknown
Verified November 2009 by Charite University, Berlin, Germany.
Recruitment status was:  Not yet recruiting
First Posted : November 13, 2009
Last Update Posted : November 13, 2009
Sponsor:
Collaborator:
Freie Universität Berlin
Information provided by:
Charite University, Berlin, Germany

Brief Summary:
The purpose of this study is to improve cognitive dysfunction following chemotherapy, the investigators investigated to see whether a cognitive training for memory and concentration skills can improve cognitive performance in patients following cancer treatment.

Condition or disease Intervention/treatment Phase
Cognitive Dysfunction Behavioral: cognitive training Other: control group Not Applicable

Detailed Description:
Patients following chemotherapy invited for a cognitive training. Before and after cognitive function will evaluate.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Training of Cognitive Function of Patients After Chemotherapy
Study Start Date : December 2009
Estimated Primary Completion Date : October 2011
Estimated Study Completion Date : October 2011

Arm Intervention/treatment
Experimental: training
Patients in this group start the cognitive training over 6 weeks directly after randomization.
Behavioral: cognitive training
cognitive training over 6 weeks, consist of 6 meetings (a 45minutes), three sessions focus on concentration tasks and three sessions on memory problems.
Other Name: training group
Placebo Comparator: control
In this control group begin the training in a cross-over design 7 weeks after randomization.
Other: control group
no intervention
Other Name: controll group



Primary Outcome Measures :
  1. several cognitive tests (TAP, VLMT, TMT, Stroop, RWT, D2, LGT-3) [ Time Frame: one weeks following the end of the cognitive training ]

Secondary Outcome Measures :
  1. quality of life and subjective perception of cognitive problems [ Time Frame: 7 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients with cancer 6 weeks after chemotherapy

Exclusion Criteria:

  • patients with neurological or psychiatric disorders
  • patients without compliance

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01013233


Contacts
Contact: Susanne Effenberger, MSc +49-30-8445-2410 susanne.effenberger@charite.de
Contact: Fernando Dimeo, MD +49-30-8445-4834 fernando.dimeo@charite.de

Locations
Germany
Charite Universitätsmedizin Berlin Not yet recruiting
Berlin, Germany, 12200
Contact: Susanne Effenberger, MSc    +49-30-8445-2410    susanne.effenberger@charite.de   
Principal Investigator: susanne Effenberger, MSc         
Sponsors and Collaborators
Charite University, Berlin, Germany
Freie Universität Berlin
Investigators
Principal Investigator: Michael Niedeggen, PhD Freie Universität Berlin

Responsible Party: Fernando Dimeo, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01013233     History of Changes
Other Study ID Numbers: KTST09
First Posted: November 13, 2009    Key Record Dates
Last Update Posted: November 13, 2009
Last Verified: November 2009

Keywords provided by Charite University, Berlin, Germany:
cognitive dysfunction chemotherapy

Additional relevant MeSH terms:
Cognitive Dysfunction
Cognition Disorders
Neurocognitive Disorders
Mental Disorders